Q4 2025 · 13F-HR
Vazirani Asset Management LLCholdings as filed
Filed 2026-02-17 · accession 0001716476-26-000001
$16.5M
Reported value
10
Positions
2025-12-31
Period end
The Brief · Vazirani Asset Management LLC · Q4 2025
AI · grounded in 13F
Vazirani Asset Management LLC closed its position in VRNA for a reduction of $6.4M. The fund also exited positions in 07WA and EA, reducing exposure by $5.3M and $2.0M respectively. To offset these sells, the manager established new positions in DAY for $3.5M and EXK for $2.5M. Additionally, the fund increased its stake in NSC by 20%.
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 655844108 | NSC | NORFOLK SOUTHN CORP | $4.3M | 26.3% | 15,000 | Common | SOLE |
| 15677J108 | DAY | DAYFORCE INC | $3.5M | 21.0% | 50,000 | Common | SOLE |
| 30063P105 | EXK | EXACT SCIENCES CORP | $2.5M | 15.4% | 25,000 | Common | SOLE |
| 35909D109 | FYBR | FRONTIER COMMUNICATIONS PARE | $1.9M | 11.6% | 50,000 | Common | SOLE |
| 20717M103 | 8QR | CONFLUENT INC | $1.8M | 11.0% | 59,920 | Common | SOLE |
| 934423104 | WBD | WARNER BROS DISCOVERY INC | $864,600 | 5.25% | 30,000 | Common | SOLE |
| 171757206 | CDTX | CIDARA THERAPEUTICS INC | $552,225 | 3.35% | 2,500 | Common | SOLE |
| 03152W109 | AM6 | AMICUS THERAPEUTICS INC | $356,000 | 2.16% | 25,000 | Common | SOLE |
| 75605Y106 | — | ANYWHERE REAL ESTATE INC | $354,000 | 2.15% | 25,000 | Common | SOLE |
| 49372L209 | 2KZ0 | KEZAR LIFE SCIENCES INC | $304,612 | 1.85% | 48,428 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.